Correction: The cGAS-STING pathway in atherosclerosis

Si-Yu Wang^{1

2

3}, Yu-Shan Chen^{1

2}, Bo-Yuan Jin^{1

2

3}, Ahmad Bilal^{1

2

3}

Affiliations

¹ Heart Center/National Regional (Traditional Chinese Medicine) Cardiovascular Diagnosis and Treatment Center, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China.
² Department of Cardiology, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China.
³ The First Clinical Medical College, Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China.

Published Erratum

Si-Yu Wang et al. Front Cardiovasc Med. 2025.

. 2025 Jun 20:12:1641100.

doi: 10.3389/fcvm.2025.1641100. eCollection 2025.

Si-Yu Wang^{1

2

3}, Yu-Shan Chen^{1

2}, Bo-Yuan Jin^{1

2

3}, Ahmad Bilal^{1

2

3}

¹ Heart Center/National Regional (Traditional Chinese Medicine) Cardiovascular Diagnosis and Treatment Center, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China.
² Department of Cardiology, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China.
³ The First Clinical Medical College, Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China.

Abstract

[This corrects the article DOI: 10.3389/fcvm.2025.1550930.].

Keywords: STING inhibitors; atherosclerosis; cGAS inhibitors; cGAS-STING pathway; risk factors; therapeutic potential.

The cGAS-STING pathway in atherosclerosis.
Wang SY, Chen YS, Jin BY, Bilal A. Wang SY, et al. Front Cardiovasc Med. 2025 Apr 25;12:1550930. doi: 10.3389/fcvm.2025.1550930. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40351606 Free PMC article. Review.